Amedeo's Top 20

Amedeo Smart

Independent Medical Education

11 September 2017

Multidisciplinary Journal Club

  1. Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, et al.
    Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    J Clin Oncol 2017;35:2288-2298.

  1. Kulik L, Heimbach JK, Zaiem F, Almasri J, et al.
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology 2017.

  2. Govindan R, Szczesna A, Ahn MJ, Schneider CP, et al.
    Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer.
    J Clin Oncol 2017.

  3. Dohner H, Estey E, Grimwade D, Amadori S, et al.
    Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
    Blood 2017;129:424-447.

  4. Kalincik T, Jokubaitis V, Spelman T, Horakova D, et al.
    Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis.
    Mult Scler 2017.

  1. Tielemans SMAJ, de Melker HE, Hahne SJM, Boef AGC, et al.
    Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
    BMJ 2017;358:j3862.

  2. Hay AD, Little P, Harnden A, Thompson M, et al.
    Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial.
    JAMA 2017;318:721-730.

  3. Ajmera VH, Terrault NA, Harrison SA.
    Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Hepatology 2017;65:2090-2099.

  4. Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, et al.
    Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    J Clin Oncol 2017.

  5. Kikuchi T, Morizane A, Doi D, Magotani H, et al.
    Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
    Nature 2017;548:592-596.

  1. Walensky RP, Borre ED, Bekker LG, Hyle EP, et al.
    Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.
    Ann Intern Med 2017.

  2. Weinstein M, Yang OO, Cohen AC.
    Were we prepared for PrEP? five years of implementation.
    AIDS 2017.

  3. Medland NA, Nicholson S, Chow EPF, Read THR, et al.
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS 2017.

  4. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, et al.
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    N Engl J Med 2017.

  5. Lipson DA, Barnacle H, Birk R, Brealey N, et al.
    FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med 2017;196:438-446.

  1. Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repesse Y, et al.
    Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
    Circulation 2017.

  2. Fisher RJ, Cobley CS, Potgieter I, Moody A, et al.
    Is Stroke Early Supported Discharge still effective in practice? A prospective comparative study.
    Clin Rehabil 2016;30:268-76.

  3. Alvarez-Del Arco D, Fakoya I, Thomadakis C, Pantazis N, et al.
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS 2017;31:1979-1988.

  4. Reiter A, Gotlib J.
    Myeloid neoplasms with eosinophilia.
    Blood 2017;129:704-714.

  5. Pratz KW, Levis M.
    How I treat FLT3-mutated AML.
    Blood 2017;129:565-571.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016